Press "Enter" to skip to content

Merck raised prices five drugs including Keytruda in November

Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including its top-selling cancer treatment Keytruda.

Original source:

Also Read:   Coronavirus infects more than 100,000 worldwide, wreaking financial havoc